Loading...
Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Loading...
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Berberis lycium
Barberry du nord-ouest himalayen ; pâte de bark (Rasaut) utilisée en médecine unani pour les affections et infections des yeux.
Berberis lycium, a Northwest Himalayan barberry, yields a bark paste (Rasaut) traditionally used in Unani medicine for ophthalmic infections and systemic conditions. Modern research supports its antimicrobial, anti-diabetic, and anti-inflammatory activities, attributed primarily to the isoquinoline alkaloid berberine, along with berbamine, palmatine, and oxyacanthine.
Berberine, the principal alkaloid, activates AMP-activated protein kinase (AMPK), enhancing insulin sensitivity and glucose uptake, while inhibiting gluconeogenesis. It also disrupts bacterial cell membranes and inhibits bacterial topoisomerase IV and DNA gyrase, conferring broad-spectrum antimicrobial effects. Anti-inflammatory actions involve suppression of NF-κB signaling and reduction of pro-inflammatory cytokines (TNF-α, IL-6). Additionally, berberine modulates gut microbiota and inhibits α-glucosidase, contributing to glycemic control.
Barberry du nord-ouest himalayen ; pâte de bark (Rasaut) utilisée en médecine unani pour les affections et infections des yeux.
Berberis lycium, a Northwest Himalayan barberry, yields a bark paste (Rasaut) traditionally used in Unani medicine for ophthalmic infections and systemic conditions. Modern research supports its antimicrobial, anti-diabetic, and anti-inflammatory activities, attributed primarily to the isoquinoline alkaloid berberine, along with berbamine, palmatine, and oxyacanthine.
Berberine, the principal alkaloid, activates AMP-activated protein kinase (AMPK), enhancing insulin sensitivity and glucose uptake, while inhibiting gluconeogenesis. It also disrupts bacterial cell membranes and inhibits bacterial topoisomerase IV and DNA gyrase, conferring broad-spectrum antimicrobial effects. Anti-inflammatory actions involve suppression of NF-κB signaling and reduction of pro-inflammatory cytokines (TNF-α, IL-6). Additionally, berberine modulates gut microbiota and inhibits α-glucosidase, contributing to glycemic control.